TfR2 expression in human colon carcinomas

Cancer Statistics, 2007

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439 · see citing works

Lipid rafts and signal transduction

Simons, K., & Toomre, D. K. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 6,252 · see citing works

Prognostic Factors in Prostate Cancer

Bostwick, D. G., Grignon, D. J., Hammond, M. E., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,365 · see citing works

Prognostic Factors in Colorectal Cancer

Compton, C. C., FIELDING, L. P., Burgart, L. J., Conley, B. A., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,251 · see citing works

The MAPK signalling pathways and colorectal cancer

Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185 · see citing works

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

Sebolt, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A. M., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A. J., Przybranowski, S. A., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 972 · see citing works

The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22

Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803 · see citing works

Molecular Cloning of Transferrin Receptor 2

Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., & Koeffler, H. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20826 · Cited by 646 · see citing works

American Joint Committee on Cancer prognostic factors consensus conference

Compton, C. C., Fenoglio‐Preiser, C. M., Pettigrew, N. M., & FIELDING, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7 · Cited by 592 · see citing works

Transferrin receptor is necessary for development of erythrocytes and the nervous system

Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F., & Andrews, N. (1999) · Nature Genetics · doi:10.1038/7727 · Cited by 574 · see citing works

Transferrin receptors in human tissues: their distribution and possible clinical relevance.

Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R.-E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 530 · see citing works

Hepcidin is decreased in TFR2 hemochromatosis

Nemeth, E., Roetto, A., Garozzo, G., Ganz, T., & Camaschella, C. (2004) · Blood · doi:10.1182/blood-2004-08-3042 · Cited by 396 · see citing works

Interaction of the Hereditary Hemochromatosis Protein HFE with Transferrin Receptor 2 Is Required for Transferrin-Induced Hepcidin Expression

Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.-S., & Enns, C. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.010 · Cited by 326 · see citing works

Transferrin receptor 2: Continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis

Fleming, R. E., Migas, M. C., Holden, C. C., Waheed, A., Britton, R. S., Tomatsu, S., Bacon, B. R., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040548097 · Cited by 273 · see citing works

New mutations inactivating transferrin receptor 2 in hemochromatosis type 3

Roetto, A., Totaro, A., Piperno, A., Piga, A. G., Longo, F., Garozzo, G., Calı̀, A., Gobbi, M. D., Gasparini, P., & Camaschella, C. (2001) · Blood · doi:10.1182/blood.v97.9.2555 · Cited by 247 · see citing works

Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo

Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., SAID, J. W., & Koeffler, H. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908846199 · Cited by 245 · see citing works

Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis

Fleming, R. E., Ahmann, J. R., Migas, M. C., Waheed, A., Koeffler, H. P., Kawabata, H., Britton, R. S., Bacon, B. R., & Sly, W. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162360699 · Cited by 244 · see citing works

Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis

Kawabata, H., Fleming, R. E., Gui, D., Moon, S. Y., Saitoh, T., O’Kelly, J., Umehara, Y., Wano, Y., SAID, J. W., & Koeffler, H. P. (2004) · Blood · doi:10.1182/blood-2004-04-1416 · Cited by 238 · see citing works

Modulation of iron transport proteins in human colorectal carcinogenesis

Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226 · see citing works

Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae.

Lisanti, M. P., Tang, Z., & Sargiacomo, M. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.3.595 · Cited by 198 · see citing works

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

Catalano, V., Loupakis, F., Graziano, F., Torresi, U., Bisonni, R., Mari, D., Fornaro, L., Baldelli, A. M., Giordani, P., Rossi, D., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604955 · Cited by 192 · see citing works

TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway

Calzolari, A., Raggi, C., Deaglio, S., Sposi, N. M., Stafsnes, M., Fecchi, K., Parolini, I., Malavasi, F., Peschle, C., Sargiacomo, M., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.03228 · Cited by 190 · see citing works

Iron and Colorectal Cancer Risk: Human Studies

Nelson, R. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07002.x · Cited by 181 · see citing works

Mucinous carcinoma—Just another colon cancer?

Green, J. B., Timmcke, A. E., Mitchell, W., Hicks, T. C., Gathright, B. J., & Ray, J. E. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02050301 · Cited by 175 · see citing works

Body Iron Stores and Risk of Colonic Neoplasia

Nelson, R. L., Davis, F. G., Sutter, E., Sobin, L. H., Kikendall, J. W., & Bowen, P. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.6.455 · Cited by 174 · see citing works

Transferrin receptor 2 is frequently expressed in human cancer cell lines

Calzolari, A., Oliviero, I., Deaglio, S., Mariani, G., Biffoni, M., Sposi, N. M., Malavasi, F., Peschle, C., & Testa, U. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.02.003 · Cited by 171 · see citing works

Two Subtypes of Mucinous Adenocarcinoma of The Colorectum: Clinicopathological and Genetic Features

Sarli, L., Bottarelli, L., Azzoni, C., Cola, G. D., Barilli, A. L., Costi, R., Mazzeo, A., Salvemini, C., Porrini, C., Cecchini, S., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9757-1 · Cited by 162 · see citing works

First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin

Wallace, D. F., Summerville, L., Lusby, P. E., & Subramaniam, V. N. (2005) · Gut · doi:10.1136/gut.2004.062018 · Cited by 160 · see citing works

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

Negri, F., Wotherspoon, A. C., Cunningham, D., Norman, A. R., Chong, G., & Ross, P. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi244 · Cited by 158 · see citing works

Primary Mucinous Adenocarcinomas and Signet-Ring Cell Carcinomas of Colon and Rectum

Secco, G. B., Fardelli, R., Campora, E., Lapertosa, G., Gentile, R., Zoli, S., & Prior, C. (2009) · Oncology · doi:10.1159/000227306 · Cited by 149 · see citing works

Regulation of expression of murine transferrin receptor 2

Kawabata, H., Germain, R. S., Ikezoe, T., Tong, X., Green, E. M., Gombart, A. F., & Koeffler, H. P. (2001) · Blood · doi:10.1182/blood.v98.6.1949 · Cited by 139 · see citing works

Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer

Shaheen, N. J., Silverman, L. M., Keku, T. O., Lawrence, L. B., Rohlfs, E. M., Martin, C. F., Galanko, J., & Sandler, R. S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.154 · Cited by 131 · see citing works

Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer

Prutki, M., Poljak‐Blaži, M., Jakopović, M., Tomas, D., Stipančić, I., & Žarković, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.001 · Cited by 129 · see citing works

Targeted Disruption of the Hepatic Transferrin Receptor 2 Gene in Mice Leads to Iron Overload

Wallace, D. F., Summerville, L., & Subramaniam, V. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.028 · Cited by 124 · see citing works

Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes

Ramey, G., Deschemin, J., & Vaulont, S. (2009) · Haematologica · doi:10.3324/haematol.2008.003541 · Cited by 122 · see citing works

Hepatic iron overload and hepatocellular carcinoma

Kew, M. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.001 · Cited by 107 · see citing works

Increased hepcidin expression in colorectal carcinogenesis

Ward, D. G., Roberts, K., Brookes, M., Joy, H., Martin, A., Ismail, T., Spychal, R., Iqbal, T. H., & Tselepis, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1339 · Cited by 105 · see citing works

Breast Carcinoma and the Role of Iron Metabolism

Elliott, R. L., Elliott, M. C., Wang, F., & Head, J. F. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17204.x · Cited by 99 · see citing works

Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics

Song, G. A., Deng, G., Bell, I., Kakar, S., Sleisenger, M. H., & Kim, Y. S. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.3.745 · Cited by 87 · see citing works

Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum

Deaglio, S., Capobianco, A., Calı̀, A., Bellora, F., Alberti, F., Righi, L., Sapino, A., Camaschella, C., & Malavasi, F. (2002) · Blood · doi:10.1182/blood-2002-01-0076 · Cited by 86 · see citing works

What we could do now: molecular pathology of colorectal cancer: Figure 1

Houlston, R. S. (2001) · Molecular Pathology · doi:10.1136/mp.54.4.206 · Cited by 73 · see citing works

Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions.

Connelly, J. H., Robey-Cafferty, S. S., & Cleary, K. R. (1991) · PubMed · Cited by 67 · see citing works

Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors

Voisin, L., Julien, C., Duhamel, S., Gopalbhai, K., Claveau, I., Saba-El-Leil, M. K., Rodrigue‐Gervais, I. G., Gaboury, L. A., Lamarre, D., Basik, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-337 · Cited by 67 · see citing works

Transferrin Saturation, Dietary Iron Intake, and Risk of Cancer

Mainous, A. G. (2005) · The Annals of Family Medicine · doi:10.1370/afm.283 · Cited by 54 · see citing works

Heterotypic interactions between transferrin receptor and transferrin receptor 2

Vogt, T. M., Blackwell, A. D., Giannetti, A. M., Björkman, P. J., & Enns, C. A. (2003) · Blood · doi:10.1182/blood-2002-09-2742 · Cited by 47 · see citing works

Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum

Kim, D., Kim, J. G., Cho, J. S., Baek, S. K., Kakar, S., Kim, G., Sleisenger, M. H., & Kim, Y. S. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.4.957 · Cited by 39 · see citing works

Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2

Pelucchi, S., Mariani, R., Trombini, P., Coletti, S., Pozzi, M., Paolini, V., Barisani, D., & Piperno, A. (2009) · Haematologica · doi:10.3324/haematol.13576 · Cited by 35 · see citing works

Transferrin receptor 2 protein is not expressed in normal erythroid cells

Calzolari, A., Deaglio, S., Sposi, N. M., Petrucci, E., Morsilli, O., Gabbianelli, M., Malavasi, F., Peschle, C., & Testa, U. (2004) · Biochemical Journal · doi:10.1042/bj20040230 · Cited by 29 · see citing works

Clinical importance of late recurrence in soft-tissue sarcomas

Gibbs, J. F., Lee, R. J., Driscoll, D. L., McGrath, B. E., Mindell, E. R., & Kraybill, W. G. (2000) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(200002)73:2 · Cited by 27 · see citing works

Clinical, histopathological, cytogenetic and prognostic differences between mucinous and nonmucinous colorectal adenocarcinomas.

Enríquez-Navascués, J. M., Díez, M., Tobaruela, E., Lozano, O., Dominguez, P. A., González, A., Mugüerza, J. M., & Ratia, T. (1998) · PubMed · Cited by 17 · see citing works

Two Subtypes of Mucinous Adenocarcinoma of the Colorectum: Clinicopathological and Genetic Features

Sarli, L., Bottarelli, L., Azzoni, C., Cola, G. D., Barilli, A. L., Costi, R., Mazzeo, A., Salvemini, C., Porrini, C., Cecchini, S., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9950-x · Cited by 5 · see citing works

Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology

Brown, R. A. M., Richardson, K. L., Kabir, T. D., Trinder, D., Ganß, R., & Leedman, P. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00476 · Cited by 279 · see citing works

Iron as a central player and promising target in cancer progression

Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works

Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas

Calzolari, A., Larocca, L. M., Deaglio, S., Finisguerra, V., Boe, A., Raggi, C., Ricci-Vitani, L., Pierconti, F., Malavasi, F., Maria, R. D., et al. (2010) · Translational Oncology · doi:10.1593/tlo.09274 · Cited by 131 · see citing works

Intestinal Iron Homeostasis and Colon Tumorigenesis

Xue, X., & Shah, Y. M. (2013) · Nutrients · doi:10.3390/nu5072333 · Cited by 83 · see citing works

Transferrin receptor 1 overexpression is associated with tumour de‐differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma

Adachi, M., Kai, K., Yamaji, K., Ide, T., Noshirο, H., Kawaguchi, A., & Aishima, S. (2019) · Histopathology · doi:10.1111/his.13847 · Cited by 81 · see citing works

Development and validation of a five-immune gene prognostic risk model in colon cancer

Chen, H., Luo, J., & Guo, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-06799-0 · Cited by 79 · see citing works

Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment

Voth, B. L., Nagasawa, D. T., Pelargos, P. E., Chung, L. K., Ung, N. M., Gopen, Q. S., Tenn, S. E., Kamei, D. T., & Yang, I. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.002 · Cited by 76 · see citing works

The RNA-binding protein ESRP1 promotes human colorectal cancer progression

Fagoonee, S., Picco, G., Orso, F., Arrigoni, A., Longo, D. L., Forni, M., Scarfò, I., Cassenti, A., Piva, R., Cassoni, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14318 · Cited by 63 · see citing works

Hypericin-Loaded Transferrin Nanoparticles Induce PP2A-Regulated BMI1 Degradation in Colorectal Cancer-Specific Chemo-Photodynamic Therapy

Sardoiwala, M. N., Kushwaha, A. C., Dev, A., Shrimali, N. M., Guchhait, P., Karmakar, S., & Choudhury, S. R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01844 · Cited by 52 · see citing works

Osteosarcoma in Children: Not Only Chemotherapy

Argenziano, M., Tortora, C., Pota, E., Paola, A. D., Martino, M. D., Leva, C. D., Pinto, D., & Rossi, F. (2021) · Pharmaceuticals · doi:10.3390/ph14090923 · Cited by 47 · see citing works

Multicomponent Synthetic Polymers with Viral-Mimetic Chemistry for Nucleic Acid Delivery

Soliman, M. E., Nasanit, R., Abulateefeh, S. R., Allen, S., Davies, M. C., Briggs, S. S., Seymour, L. W., Preece, J. A., Grabowska, A. M., Watson, S. A., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200108q · Cited by 43 · see citing works

Time and cell‐dependent effects of endocytosis inhibitors on the internalization of biomolecule markers and nanomaterials

Sasso, L., Purdie, L., Grabowska, A. M., Jones, A. T., & Alexander, C. (2018) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.39 · Cited by 39 · see citing works

Transferrin‐Mediated Rapid Targeting, Isolation, and Detection of Circulating Tumor Cells by Multifunctional Magneto‐Dendritic Nanosystem

Banerjee, S. S., Jalota‐Badhwar, A., Satavalekar, S. D., Bhansali, S. G., Aher, N. D., Mascarenhas, R. R., Paul, D., Sharma, S., & Khandare, J. J. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200164 · Cited by 33 · see citing works

Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology

Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31 · see citing works

Multifaceted nature of membrane microdomains in colorectal cancer

Jahn, K. A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i6.681 · Cited by 29 · see citing works

Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer

Elmorshedy, Y. M., Teleb, M., Sallam, M. A., Elkhodairy, K. A., Bahey-El-Din, M., Ghareeb, D. A., Abdulmalek, S. A., Monaim, S. A. H. A., Bekhit, A. A., Elzoghby, A. O., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00037 · Cited by 28 · see citing works

Enhancing Surface Interactions with Colon Cancer Cells on a Transferrin‐Conjugated 3D Nanostructured Substrate

Banerjee, S. S., Paul, D., Bhansali, S. G., Aher, N. D., Jalota‐Badhwar, A., & Khandare, J. J. (2012) · Small · doi:10.1002/smll.201102354 · Cited by 20 · see citing works

TFR2-Related Hereditary Hemochromatosis

Gobbi, M. D., & Roetto, A. (2011) · Institutional Research Information System University of Turin (University of Turin) · Cited by 12 · see citing works

Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study

Jin, T., Ge, L., Chen, J., Wang, W., Zhang, L., & Ge, M. (2023) · PeerJ · doi:10.7717/peerj.15592 · Cited by 8 · see citing works

Complete epigenomic and genomic analysis of transcriptome modulation within skin cutaneous melanoma

Xue, D., Cheng, P., Jiang, J., Ren, Y., Wu, D., & Chen, W. (2020) · Medical Science Monitor · doi:10.12659/msm.921133 · Cited by 8 · see citing works

Low expression of transferrin receptor 2 predict poor prognosis in gastric cancer patients

Zhao, Q., Ji, J. F., Cai, Q., Wang, C., Shi, M., Zhou, C., Zhu, Z., & Zhang, J. (2020) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12278 · Cited by 8 · see citing works

Reconstituted Super Paramagnetic Protein “Magnetotransferrin” for Brain Targeting to Attenuate Parkinsonism

Sardoiwala, M. N., Sood, A., Biswal, L., Choudhury, S. R., & Karmakar, S. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20990 · Cited by 7 · see citing works

Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer

Yang, Y., Du, J., Huang, Y., He, W., Liu, L.-Z., Li, D., & Chen, R. (2023) · Oncology Letters · doi:10.3892/ol.2023.14176 · Cited by 6 · see citing works

Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer

Li, J., Han, T., Wang, X., Wang, Y., Chen, X., Chen, W., & Yang, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.851373 · Cited by 4 · see citing works

Iron Vulnerability of Cancer Stem Cells

Nengroo, M. A., Sinha, A., & Datta, D. B. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_235 · Cited by 2 · see citing works

Iron, Cancer, and Hypoxia-Inducible Factor Signaling

Xue, X., & Shah, Y. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00017-8

Iron Vulnerability of Cancer Stem Cells

Nengroo, M. A., Sinha, A., & Datta, D. B. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_235-1

Correlations between genetically predicted iron-supplement drug targets and inflammatory bowel disease: A Mendelian randomization study

Li, D., Jiang, C., Guan, Z.-A., Ma, L.-L., & Cui, W.-W. (2025) · Medicine · doi:10.1097/md.0000000000042729

Additional file 1 of Development and validation of a five-immune gene prognostic risk model in colon cancer

Chen, H., Luo, J., & Guo, J. (2020) · Figshare · doi:10.6084/m9.figshare.12262538

Additional file 3 of Development and validation of a five-immune gene prognostic risk model in colon cancer

Chen, H., Luo, J., & Guo, J. (2020) · Figshare · doi:10.6084/m9.figshare.12262544

Additional file 2 of Development and validation of a five-immune gene prognostic risk model in colon cancer

Chen, H., Luo, J., & Guo, J. (2020) · Figshare · doi:10.6084/m9.figshare.12262541

Etude du récepteur à la transferrine de type 2 dans l'érythropoïese.

Richard, C. (2019) · doi:10.70675/c36ec54fz3a93z404cz8641z05a8f1db21d5

Transferrin receptor 2 is frequently expressed in human cancer cell lines

Calzolari, A., Oliviero, I., Deaglio, S., Mariani, G., Biffoni, M., Sposi, N. M., Malavasi, F., Peschle, C., & Testa, U. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.02.003 · Cited by 171 · see citing works

Transferrin receptor‐mediated iron uptake is essential for colon tissue homeostasis

Kim, H., & Xue, X. (2022) · The FASEB Journal · doi:10.1096/fasebj.2022.36.s1.r2627

IDDF2022-ABS-0024 Transferrin receptor-mediated iron uptake is essential for colon tumorigenesis

Xue, X., & Kim, H. (2022) · doi:10.1136/gutjnl-2022-iddf.33 · Cited by 1 · see citing works

Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis

Kim, H., Villareal, L., Liu, Z., Haneef, M., Falcon, D. M., Martin, D. R., Lee, H., Dame, M. K., Attili, D., Chen, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202207693 · Cited by 95 · see citing works

Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer

Prutki, M., Poljak‐Blaži, M., Jakopović, M., Tomas, D., Stipančić, I., & Žarković, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.001 · Cited by 129 · see citing works